VC GURU
NuevaBio logo

NuevaBio

Crunchbase
Crunchbase

Deals on record

2

Common Fundraising Type

Series A

OrsoBio logo
OrsoBio

Biopharmaceutical

Ascenta Capital logo
Woodline Partners logo
Samsara Biocapital logo
NuevaBio logo
Longitude Capital logo
Enavate Sciences logo
Eli Lilly and Company logo

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Series B
$67M
09/06/2024
Article
OrsoBio logo
OrsoBio

Biopharmaceutical

Samsara BioCapital logo
Longitude Capital logo
Enavate Sciences logo
NuevaBio logo
Eli Lilly and Company logo

OrsoBio, Inc. is a clinical-stage biopharmaceutical company developing novel mitochondrial protonophore therapies targeting obesity and associated metabolic disorders.

Series A
$60M
11/07/2023
Article